Objective-Patients with bicuspid aortic valve (BAV) have an increased risk of developing ascending aortic aneurysms.Transforming growth factor-β (TGFβ) is a crucial factor of vascular remodeling, the impaired signaling of which can alter the structure and composition of the extracellular matrix. In this study, we analyzed the activity of TGFβ in aneurysmal and nonaneurysmal ascending aorta from BAV patients, using tricuspid aortic valve (TAV) patients as a reference group. Approach and Results-The response to exogenous TGFβ was analyzed with regard to gene expression in primary aortic smooth muscle cells that were isolated from 7 BAV and 5 TAV patients and in valve fibroblasts from 7 BAV and 8 TAV patients. The set of genes that were significantly changed by TGFβ (217 genes) was compared with gene expression profiles of the ascending aorta from BAV and TAV patients (139 arrays). By principle component analysis, based on the 217 genes, gene expression differed significantly in the intima/media region between aneurysmal BAV and TAV aortas, driven by the response in TAV patients. During aneurysm development the levels of phosphorylated SMADs and the availability of free TGFβ were lower in BAV patients compared with TAV. Confocal microscopy analysis showed a higher colocalization of latency associated peptide and latent TGFβ binding protein 3 in BAV aortas. as a biologically inactive form in the extracellular matrix in the large latent TGFβ1 complex, which contains a TGFβ1 homodimer, latency-associated peptide (LAP), and latent TGFβ1-binding proteins (LTBPs). Alternatively, TGFβ1 is bound in the small latent complex, which comprises a TGFβ1 homodimer and LAP. Release of the large latent complex from the extracellular matrix (catalyzed by metalloproteinases) and dissociation of TGFβ1 from LAP are required for its activation and biological activity. The pathophysiological mechanisms of BAV-associated aortopathy are unknown, but TGFβ signaling has been implicated in BAV pathology. 8,9 Previous studies have suggested that the development of aneurysm in BAV patients is characterized by lower TGFβ activity compared with tricuspid aortic valve (TAV) patients, distinguishing BAV-associated aneurysms from monogenic TAAs, based on data that fibrosis, which is stimulated by TGFβ, 10 increases during the development of aneurysms in TAV but not BAV patients.
Conclusions-Our11,12 Moreover, inclusion of the extra domain A exon in the fibronectin gene, which is upregulated by TGFβ, is more frequent during the development of aneurysms in TAV versus BAV patients.
13Because the lack of fibrosis and the differential splicing of fibronectin could be attributed to disparate TGFβ responses between BAV and TAV patients, we examined TGFβ signaling in aortic smooth muscle cells (AoSMCs) from BAV and TAV patients. To identify such differences in TGFβ responsiveness, gene expression profiles were constructed after TGFβ treatment of AoSMCs and valvular fibroblasts from patients with BAV and TAV. The resulting genes were then analyzed in express...